Literature DB >> 19924023

Glucagon like peptide-1-directed human embryonic stem cells differentiation into insulin-producing cells via hedgehog, cAMP, and PI3K pathways.

Hongxiang Hui1, Yongming G Tang, Lunjian Zhu, Nasif Khoury, Zhe Hui, Kevin Yuqi Wang, Ricardo Perfetti, Vay Liang W Go.   

Abstract

OBJECTIVES: That glucagonlike peptide-1 (GLP-1) induces differentiation of primate embryonic stem (ES) cells into insulin-producing cells has been reported by several groups and also confirmed with our observations.
METHODS: To further elucidate the process in detail and the signaling pathways involved in this differentiation, we induced human ES cells HUES1 differentiated into insulin secretion cells by GLP-1 treatment.
RESULTS: A time-dependent pattern of down expression of the stem cell markers (human telomerase reverse transcriptase and octamer-4), and the appearance of multiple beta-cell-specific proteins (insulin, glucokinase, glucose transporter, type 2, and islet duodenal homeobox 1) and hedgehog signal molecules (Indian hedgehog, sonic hedgehog, and hedgehog receptor, patched) have been identified. Cotreatment with hedgehog signal inhibitor cytopamine was able to block this differentiation, providing evidence of the involvement of the hedgehog signaling pathway in GLP-1-induced differentiation. We also observed increased transcripts of the transcription factors of activator protein 1, serum response element-1, DNA-binding transcription factors, and cAMP response element in GLP-1-induced ES cell differentiation. Inhibition profile by its specific inhibitors indicated that the cyclic adenosine monophosphate and phosphatidylinositol-3-kinase pathways, but not the mitogen-activated protein kinase pathway, were required for the induced differentiation of ES cells.
CONCLUSIONS: These data support that GLP-1 directs human ES cell differentiation into insulin-producing cells via hedgehog, cyclic adenosine monophosphate, and phosphatidylinositol-3-kinase pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19924023     DOI: 10.1097/MPA.0b013e3181bc30dd

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  8 in total

1.  Genetic modification of primate amniotic fluid-derived stem cells produces pancreatic progenitor cells in vitro.

Authors:  Yu Zhou; David L Mack; J Koudy Williams; Sayed-Hadi Mirmalek-Sani; Emily Moorefield; So-Young Chun; Jun Wang; Diego Lorenzetti; Mark Furth; Anthony Atala; Shay Soker
Journal:  Cells Tissues Organs       Date:  2013-01-08       Impact factor: 2.481

2.  The global transcriptional response of isolated human islets of langerhans to glucagon-like Peptide-1 receptor agonist liraglutide.

Authors:  Xiaoning Zhao; Yongming G Tang; S Vincent Wu; Charles Wang; Ricardo Perfetti; Nasif Khoury; Dehong Cai; Fang He; Xiaogang Su; Vay Liang W Go; Hongxiang Hui
Journal:  ISRN Endocrinol       Date:  2012-09-29

3.  Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny.

Authors:  T Thatava; T J Nelson; R Edukulla; T Sakuma; S Ohmine; J M Tonne; S Yamada; Y Kudva; A Terzic; Y Ikeda
Journal:  Gene Ther       Date:  2010-11-04       Impact factor: 5.250

4.  In Vitro Proliferation of Porcine Pancreatic Islet Cells for β-Cell Therapy Applications.

Authors:  Guoguang Niu; John P McQuilling; Yu Zhou; Emmanuel C Opara; Giuseppe Orlando; Shay Soker
Journal:  J Diabetes Res       Date:  2016-12-06       Impact factor: 4.011

5.  Glucagon-Like Peptide-1 Receptor Agonist Protects Dorsal Root Ganglion Neurons against Oxidative Insult.

Authors:  Mohammad Sarif Mohiuddin; Tatsuhito Himeno; Rieko Inoue; Emiri Miura-Yura; Yuichiro Yamada; Hiromi Nakai-Shimoda; Saeko Asano; Makoto Kato; Mikio Motegi; Masaki Kondo; Yusuke Seino; Shin Tsunekawa; Yoshiro Kato; Atsushi Suzuki; Keiko Naruse; Koichi Kato; Jiro Nakamura; Hideki Kamiya
Journal:  J Diabetes Res       Date:  2019-02-21       Impact factor: 4.011

Review 6.  Pancreatic β cell regeneration induced by clinical and preclinical agents.

Authors:  Kang-Li Wang; Ming Tao; Tian-Jiao Wei; Rui Wei
Journal:  World J Stem Cells       Date:  2021-01-26       Impact factor: 5.326

7.  Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms.

Authors:  Belén Picatoste; Elisa Ramírez; Alicia Caro-Vadillo; Cristian Iborra; Sara Ares-Carrasco; Jesús Egido; José Tuñón; Oscar Lorenzo
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

8.  Effect of sidt2 Gene on Cell Insulin Resistance and Its Molecular Mechanism.

Authors:  Qian-Ying Xiong; Chao-Qun Xiong; Li-Zhuo Wang; Jia-Lin Gao
Journal:  J Diabetes Res       Date:  2020-09-11       Impact factor: 4.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.